For: | Alqahtani SA, Colombo MG. Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma . World J Gastrointest Oncol 2021; 13(12): 2038-2049 [PMID: 35070040 DOI: 10.4251/wjgo.v13.i12.2038] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v13/i12/2038.htm |
Number | Citing Articles |
1 |
Antonio Speciale, Claudia Muscarà, Maria Sofia Molonia, Mariateresa Cristani, Francesco Cimino, Antonella Saija. Recent Advances in Glycyrrhetinic Acid-Functionalized Biomaterials for Liver Cancer-Targeting Therapy. Molecules 2022; 27(6): 1775 doi: 10.3390/molecules27061775
|
2 |
Haiyuan Li, Lei Gao, Xiaojuan Kang, Xueyan Wang, Yang Yu, Yaqing Zhang, Hao Chen. RPS24 Is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(1): 806 doi: 10.3390/ijms24010806
|
3 |
Janak Bahirwani, Suruchi Jai Kumar Ahuja, Madhav Changela, Het Patel, Nishit Patel, Maulik Kaneriya, Vishal Patel. Relative treatment effects of first-line chemotherapy and immunotherapy for hepatocellular carcinoma: A systematic review and meta-analysis. Cancer Pathogenesis and Therapy 2025; doi: 10.1016/j.cpt.2025.04.003
|
4 |
Aryanna Sousa, Qusai Al Masad, Paola Pena, N. Joseph Espat, Abdul S. Calvino, Ponnandai Somasundar, Thaer Abdelfattah, Steve Kwon. Impact of immunotherapy on the care patterns and outcomes of patients with advanced hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2025; 49(3): 102542 doi: 10.1016/j.clinre.2025.102542
|
5 |
Yan Jiao, Ye Gao, JiaYao Wang, Huanxiao An, Yi Xiang Li, Xi Zhang. Intelligent porphyrin nano-delivery system for photostimulated and targeted inhibition of angiogenesis. International Journal of Pharmaceutics 2022; 621: 121805 doi: 10.1016/j.ijpharm.2022.121805
|